Does breast-feeding protect against infections in infants less than 3 months of age?

Pediatrics
|November 1, 1986
PubMed

Insights

Breast-feeding may not protect infants from infections, but it appears to reduce hospitalizations. This study suggests careful consideration of surveillance bias is crucial when evaluating infant health outcomes.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Infant infections pose significant health risks.
  • Breast-feeding is widely recommended for infant health.
  • Understanding the true protective effects of breast-feeding is essential.

Purpose of the Study:

  • To investigate if breast-feeding protects infants against infectious illnesses.
  • To assess the impact of breast-feeding on infant hospitalization rates.
  • To identify potential biases in studies evaluating breast-feeding benefits.

Main Methods:

  • A case-control study design was employed.
  • Infants hospitalized for infectious illness (cases) were compared to healthy infants (controls).
  • Logistic regression and stratification by illness severity were used to control for confounders and bias.

Main Results:

  • Overall, breast-feeding showed a protective effect against infections (OR=0.50).
  • This effect diminished significantly when stratified by illness severity.
  • Breast-feeding was associated with reduced hospitalization for mild illnesses (OR=0.17) but not serious ones (OR=0.79).

Conclusions:

  • Breast-feeding may protect infants from hospitalization rather than directly from infections.
  • Surveillance bias could lead to overestimating the protective effect of breast-feeding against infections.
  • Further research is needed to clarify the relationship between breast-feeding and infant infection rates.

Related Concept Videos

Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...